IOANA BIELEK: Open Payments
NPI 1861045825 · MARLBORO, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,457 in 85 payments from 13 companies in 2025. Trend: 2023 $764 · 2024 $1,556 · 2025 $1,457
Food & beverage: $1,457
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 31 | $399 |
| UCB, Inc. | 18 | $369 |
| PFIZER INC. | 14 | $218 |
| Axsome Therapeutics, Inc. | 2 | $140 |
| Otter Pharmaceuticals, LLC | 5 | $90 |
| SK Life Science, Inc. | 3 | $53 |
| Aucta Pharmaceuticals, Inc. | 4 | $46 |
| Neurelis, Inc. | 3 | $45 |
| ACADIA Pharmaceuticals Inc | 1 | $25 |
| Alexion Pharmaceuticals, Inc. | 1 | $20 |
Products named: Fintepla, NURTEC ODT, UBRELVY, QULIPTA, Symbravo, SYMPAZAN, Briviact, Nayzilam.
Industry payments across NJ — which companies pay providers there.
